Progressive supranuclear palsy presenting with psychiatric features

British Journal of Clinical Practice

Volumn 50, Issue 1, 1996, Pages 60-61

  Chiu, Hfk ^a   Li, S W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

AGED; ARTICLE; BEHAVIOR DISORDER; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; EARLY DIAGNOSIS; GAZE PARALYSIS; HUMAN; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY;

AGED; FLUOXETINE; HUMANS; MALE; MENTAL DISORDERS; SEROTONIN UPTAKE INHIBITORS; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0030034822     PISSN: 00070947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Steele JC. Richardson JC. Olszewski J. Progressive supranuclear palsy. Arch Neiirol 1964: 10: .131-359.
2. Golbe LI. Davis PH. Schoenberg BS et al. Prevalence and natural history of progressive supranuclear palsy. Neumfagv 1988: 38: 1031-11)34.
3. Lees AJ. The Steele-Richardson-Olszewski syndrome. In: Marsden CD. Fahn S. Eds. Movement Disorders. 2nd edn. London: Butterworths. 1987: 272-287.
4. Kvale JN. Amitriptyline in the management of progressive supranuclear palsy. An-h fuml 1982; 39: 387-388.
5. Schneider LS, Gleason RP, Chui H. Progressive supranuclear palsy with agitation: response to tra/odone but not to thiothixene or carbamazepine. J Gt'riatr Psvchiatry eunil I987; 2: 109-112.
6. Sobin P. Schneider LS. McDermot H. Fluoxetine for the treatment of agitated dementia. Am J Psychiatry 1989: 146: 1636.